Goals
Having worked for over 25 years in small biotechnology companies I am open to a senior management position in a large or mid-size biotech company or within a university setting, including VP level positions.
Professional Positions and Highlights:
1994 to Present
President
Privately Held Biotechnology Company
As co-founder, oversaw all startup, funding activities and maintained full P&L Responsibility.
In-licensed multiple technology platforms from Cornell University.
Identified potential sublicense companies and oversaw feasibility studies at Cornell University to demonstrate utility of various technologies in particular commercial applications. Efforts included applications in biodefense, human diagnostics, environmental, and personal care markets.
Established working relationships on a worldwide basis with corporations ranging in size from multimillion to multibillion dollar annual revenues.
Actively collaborated with Cornell University scientists to transform a simple dip-stick diagnostic test platform into a sophisticated, microfluidic lab-on-a-chip with applications in multiple market niches.
As Principal Investigator, won over $ 2.9 Million in Federal and State Grants to support research efforts at Cornell University.
Currently Principal Investigator on three Federal Grants totalling approximately $1.0 Million (NIH, EPA, USDA).
Managed Intellectual Property portfolio strategy, including four patents and one patent application as inventor.
1982 to 1993
President
Publicly Traded Biotechnology Company.
As co-founder, oversaw all startup activities and IPO and maintained full P&L Responsibilities.
Invited to testify before the Presidential AIDS Commission regarding the prevalence of HTLV-I antibodies in the U.S. blood donor population. Recommendation to initiate mandatory blood screening led to nationwide testing in 1988.
Led development and FDA approval of several human diagnostic products.
Established a collegial rather than adversarial relationship with U.S. Food & Drug Administration, providing a means for a small company to compete in a regulated marketplace dominated by large, multinational companies.
Prepared and oversaw all Investigative New Drug applications, Product License and Establishment License Applications at FDA, saving the company hundreds of thousands of dollars.
Administered multiple FDA clinical trials (including design and performance) and presented all results to FDA Advisory committees to gain approval of several licensed Biological products.
Served as Responsible Head in all interactions with FDA.
Developed large-scale methods to isolate and purify human retrovirus (HIV-1 and HTLV-I) proteins for diagnostic purposes.
Oversaw design and construction of two separate biocontainment laboratories, at a combined cost of $ 2.5 Million that were successfully licensed by the U.S. FDA for production of human diagnostic products.
Directed the commercialization of over 40 biotechnology products.
Responsible for preparing & filing all Securities & Exchange submissions (i.e., 10Q and 10K filings).
Responsible for all shareholder/investor relations activities.
2006 to Present
Member, Advisory Committee
County Regional Development Corporation
Life Sciences Loan Fund
Provided evaluation to loan committee of technologies that form the basis of business plans seeking funding from the RDC loan fund.
1999 to Present
Courtesy (Adjunct) Professor
Cornell University
Ithaca, New York
Provided guest lectures in several departments.
Assisted in the guidance of graduate students and post-doctoral fellows in independent research.
Actively participated in multiple ongoing research programs designed to develop nanotechnology-based biosensors for detection of analytes including bioterrorist agents, food/water pathogens and medical diagnostics.
1996 to 1998
Director
New York Biotechnology Association
New York, New York
Oversaw activities of the not-for-profit trade association focused on the development and growth of New York based biotechnology related industries and institutions and provided advice and recommendations to Executive Director.
1995 to 2000
Member, Outside Advisory Board
Cornell University Center for Advancement of Technology
Cornell University
Ithaca, New York
Provided outside advice and recommendations to the Executive Director of the Cornell University Center for Advancement of Technology regarding research programs to be funded at the university in the area of Biotechnology.
1994 to 1996
Member, Advisory Board
NY State Council on Agricultural Technology & Innovation
Albany, New York
Appointed by New York State Governor to serve a two-year term on the Council focused on exploiting innovations developed within New York State for improving agricultural output within the state.
1980 to 1982
Director of Biological Operations
Privately Held Biotechnology Company
Buffalo, New York
Oversaw all research & development and manufacturing activities of company, including large-scale cell culture & protein purification efforts.
Responsible for scientific administration of a multi-year, multi-million dollar NIH supply contract to Robert C. Gallo, M.D.
Education & Training:
Ph.D. (1976)
Division of Cell & Molecular Biology
State University of New York, Buffalo, New York
National Institutes of Health Fellow in Experimental Pathology (1976)
New York University Medical Center
New York, New York
Post-Doctoral Fellow (1977 to 1978)
University of Texas System Cancer Center
M.D. Anderson Hospital & Tumor Institute
Houston, Texas
Research Associate (1979 to 1980)
University of Texas System Cancer Center
M.D. Anderson Hospital & Tumor Institute
Houston, Texas
INVITED PRESENTATIONS (last 3 years):
International Food Technologists Annual Meeting, Orlando, Florida, June 25, 2006.
International Food Technologists Annual Meeting, New Orleans, LA, July 16, 2005.
Workshop on the Feasibility of using DNA/RNA Microarrays and Related Technologies for High Throughput Detection of Waterborne Pathogens, U.S. Environmental Protection Agency, Cincinnati, Ohio, March 22, 2005.
Upstate New York Biotech Day, University of Rochester Medical Center, sponsored by Johnson & Johnson, October 10, 2005.
School of Management, State University of New York at Buffalo, September 28, 2004.
BioBuffalo Meeting, Buffalo, New York, July 21, 2004.
PATENTS - Four issued and one pending patent in the field of biosensors
RESEARCH GRANTS AWARDED (as Principal Investigator)
Agency: NIAID/NIH
Dates of Performance: 2/1/2008 to 7/31/08
Amount of Support: $99,975
Agency: U.S. Department of Agriculture
Dates of Performance: 1/1/2007 to 12/31/2008
Amount of Support: $ 500,000
Agency: U.S. Environmental Protection Agency
Dates of Performance: 5/01/2006 to 4/30/2009
Amount of Support: $ 345,000
Agency: U.S. Environmental Protection Agency
Dates of Performance: 3/01/2006 to 8/31/2006
Amount of Support: $ 69,984
Agency: National Institute of Allergy & Infectious Diseases
Dates of Performance: 4/1/2005 to 3/31/2006
Amount of Support: $ 200,271
Agency: National Institute of Allergy & Infectious Diseases
Dates of Performance: 4/1/2004 to 3/31/2005
Amount of Support: $ 200,271
Agency: National Institute of Allergy & Infectious Diseases
Dates of Performance: 3/15/2003 to 2/28/2004
Amount of Support: $ 425,547
Agency: National Institute of Allergy & Infectious Diseases
Dates of Performance: 3/15/2002 to 2/28/2003
Amount of Support: $ 413,335
Agency: New York State Energy Research & Development Authority (NYSERDA)
Dates of Performance: 8/1/2000 to 7/31/2002
Amount of Support: $ 149,438
Agency: National Institute of Allergy & Infectious Diseases
Dates of Performance: 6/1/2000 to 11/30/2000
Amount of Support: $ 98,134
Agency: New York State Energy Research & Development Authority (NYSERDA)
Dates of Performance: 11/1/1997 to 1/31/2004
Amount of Support: $ 448,558
PUBLICATIONS
38 peer-reviewed (available upon request) |
